Obredon

Active Ingredient(s): Hydrococone Bitartrate + Guaifenesin
FDA Approved: * November 14, 2014
Pharm Company: * SOVEREIGN PHARMA LLC
Category: Allergies, Cough & Cold

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Obredon Overview

Hydrocodone, sold under the brand name Hysingla among others, is an opioid used to treat severe pain of a prolonged duration, if other measures are not sufficient.[9][10] It is also used as a cough suppressant in adults.[9] It is taken by mouth.[9] Typically it is sold as the combinations acetaminophen/hydrocodone or ibuprofen/hydrocodone.[9][11] By itself it is sold in a long-acting formulation.&a...

Read more Obredon Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Hydrocodone

Recent Obredon Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Hydrococone Bitartrate + Guaifenesin
  • Liquid: 100mg/5ml + 5mg/5ml, 200mg/5ml + 6mg/5ml, 350mg/5ml + 5mg/5ml
  • Solution: 100mg/5ml + 5mg/5ml, 2.5mg + 200mg/5ml, 2.5mg + 5ml, 200mg + 5ml, 200mg/5ml + 2.5mg/5ml
  • Syrup: 100mg + 5mg, 100mg/5ml + 2.5mg/5ml, 100mg/5ml + 5mg/5ml, 200mg/5ml + 2.5mg/5ml, 90mg/5ml + 3mg/5ml
  • Tablet: 300mg + 2.5mg, 5;300mg/mg + 5;300mg/mg, 575mg + 5mg
  • Tablet, Extended Release: 600mg + 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Obredon: (2 results)

Sorted by National Drug Code
  • 58716-433 Obredon Oral Solution by Sovereign Pharmaceuticals, LLC
  • 69166-523 Obredon Oral Solution by Novotec Pharma LLC

Drugs with one or more similar ingredients: (236 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 28 February 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA